Articles published by DBV Technologies S.A.
Via GlobeNewswire
Tickers
DBVT
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
January 08, 2025
Via GlobeNewswire
Tickers
DBVT
DBV Technologies Announces Plan to Implement ADS Ratio Change
November 11, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Technologies Reports Third Quarter 2024 Financial Results
November 06, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
October 22, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
October 18, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
September 23, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
Via GlobeNewswire
Tickers
DBVT
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
March 04, 2024
Via GlobeNewswire
Tickers
DBVT
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
February 20, 2024
Via GlobeNewswire
Tickers
DBVT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.